These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1558197)

  • 1. Role of intracellular thiols in release of EDRF from cultured endothelial cells.
    Hecker M; Siegle I; Macarthur H; Sessa WC; Vane JR
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H888-96. PubMed ID: 1558197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkaline buffers release EDRF from bovine cultured aortic endothelial cells.
    Mitchell JA; de Nucci G; Warner TD; Vane JR
    Br J Pharmacol; 1991 Jun; 103(2):1295-302. PubMed ID: 1884092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfhydryl-depleting agents, but not deferoxamine, modulate EDRF action in cultured pulmonary arterial cells.
    Marczin N; Ryan US; Catravas JD
    Am J Physiol; 1993 Sep; 265(3 Pt 1):L220-7. PubMed ID: 8214082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrasting effects of thiol-modulating agents on endothelial NO bioactivity.
    Huang A; Xiao H; Samii JM; Vita JA; Keaney JF
    Am J Physiol Cell Physiol; 2001 Aug; 281(2):C719-25. PubMed ID: 11443071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the release of endothelium-derived relaxing factor in vitro and in vivo by dipeptides containing NG-nitro-L-arginine.
    Thiemermann C; Mustafa M; Mester PA; Mitchell JA; Hecker M; Vane JR
    Br J Pharmacol; 1991 Sep; 104(1):31-8. PubMed ID: 1786515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different patterns of release of endothelium-derived relaxing factor and prostacyclin.
    Mitchell JA; de Nucci G; Warner TD; Vane JR
    Br J Pharmacol; 1992 Feb; 105(2):485-9. PubMed ID: 1373103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Release of endothelium-derived relaxing factor (EDRF) from cultured vascular endothelial cells depends on extra- and intracellular Ca2+ concentrations].
    Korenaga R
    Hokkaido Igaku Zasshi; 1993 Sep; 68(5):744-54. PubMed ID: 8225180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous populations of K+ channels mediate EDRF release to flow but not agonists in rabbit aorta.
    Hutcheson IR; Griffith TM
    Am J Physiol; 1994 Feb; 266(2 Pt 2):H590-6. PubMed ID: 7511348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of prostacyclin and EDRF from endothelial cells is differentially controlled by extra- and intracellular calcium.
    Lückhoff A
    Eicosanoids; 1988; 1(1):5-11. PubMed ID: 3152425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N omega-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation.
    Ishii K; Chang B; Kerwin JF; Huang ZJ; Murad F
    Eur J Pharmacol; 1990 Feb; 176(2):219-23. PubMed ID: 2155799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential role of extra- and intracellular calcium in the release of EDRF and prostacyclin from cultured endothelial cells.
    Lückhoff A; Pohl U; Mülsch A; Busse R
    Br J Pharmacol; 1988 Sep; 95(1):189-96. PubMed ID: 3064851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escherichia coli endotoxin inhibits agonist-mediated cytosolic Ca2+ mobilization and nitric oxide biosynthesis in cultured endothelial cells.
    Graier WF; Myers PR; Rubin LJ; Adams HR; Parker JL
    Circ Res; 1994 Oct; 75(4):659-68. PubMed ID: 7923612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of bovine endothelial thromboxane receptors triggers release of prostacyclin but not EDRF.
    Clesham G; Parsaee H; Joseph S; McEwan JR; MacDermot J
    Cardiovasc Res; 1992 May; 26(5):513-7. PubMed ID: 1446322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial cGMP does not regulate basal release of endothelium-derived relaxing factor in culture.
    Marczin N; Ryan US; Catravas JD
    Am J Physiol; 1992 Jul; 263(1 Pt 1):L113-21. PubMed ID: 1379001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial cyclic GMP and cyclic AMP do not regulate the release of endothelium-derived relaxing factor/nitric oxide from bovine aortic endothelial cells.
    Kuhn M; Otten A; Frölich JC; Förstermann U
    J Pharmacol Exp Ther; 1991 Feb; 256(2):677-82. PubMed ID: 1847208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells.
    Förstermann U; Pollock JS; Schmidt HH; Heller M; Murad F
    Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1788-92. PubMed ID: 1705708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the release of vasoactive factors from venous and arterial bovine cultured endothelial cells.
    D'Orleans-Juste P; Mitchell JA; Wood EG; Hecker M; Vane JR
    Can J Physiol Pharmacol; 1992 May; 70(5):687-94. PubMed ID: 1423010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential sensitivities of the prostacyclin and nitric oxide biosynthetic pathways to cytosolic calcium in bovine aortic endothelial cells.
    Parsaee H; McEwan JR; Joseph S; MacDermot J
    Br J Pharmacol; 1992 Dec; 107(4):1013-9. PubMed ID: 1361398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-arginine, but not N alpha-benzoyl-L-arginine ethyl ester, is a precursor of endothelium-derived relaxing factor.
    Fasehun OA; Gross SS; Rubin LE; Jaffe EA; Griffith OW; Levi R
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1348-53. PubMed ID: 2175803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release.
    Vargas HM; Cuevas JM; Ignarro LJ; Chaudhuri G
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1208-15. PubMed ID: 1646327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.